Back

Potential cardio-protective role of dapagliflozin in diabetic patients presented with anterior ST-elevation myocardial infarction (STEMI).

13 May 2024 (13:00 - 14:00)
Organised by: Logo
Congress Presentation Part of: ePosters in acute heart failure 12 Pharmacotherapy HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Ayman Ibrahim

Aswan university hospital, Aswan (Egypt)

7 More presentations in this session

Presentation thumbnail
Temporal trends in guideline-directed medical therapy prescription and 30-day readmission after heart failure hospitalization
Doctor R. Laborante (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Unlocking stability: predictors of clinical stability in patients undergoing intermittent levosimendan infusions for advanced heart failure
Doctor F. Gerardo (Amadora, PT)
Abstract Slides Video
Presentation thumbnail
Adherence to quadruple therapy for heart failure. A single-center experience in LMIC
Doctor A. Khan (Peshawar, PK)
Abstract Slides Video
Presentation thumbnail
Impact on hospitalisation and safety of high doses of torasemide in advanced or end-stage decompensated heart failure
Doctor T. Castiello (London, GB)
Abstract Slides Video
Presentation thumbnail
Use of guideline-directed medical therapy in women hospitalised for decompensated heart failure
Doctor T. Furlan (Trbovlje, SI)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in acute heart failure 12

The Event

Event poster

Heart Failure 2024

13 May 2024 13:00 CET
You may be interested in
thumbnail
Congress Presentation
Efficacy of in-hosptal initiation of dapagliflozin in prevention of heart failure in non-diabetic patients with anterior wall ST-segment elevation acute myocardial infarction
thumbnail
Congress Presentation
Efficacy and safety of dapagliflozin in non-diabetic patients with primary anterior ST-elevation myocardial infarction initiated in early hospital period
thumbnail
Congress Presentation
Dapagliflozin effect on cardiopulmonary function, reverse cardiac remodelling and biomarkers in a cohort of HFrEF patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources